Baylor Scientists Find Tubulin Blocks 2 Toxic Brain Proteins in Alzheimer’s and Parkinson’s
Updated
Updated · ScienceDaily · Jun 21
Baylor Scientists Find Tubulin Blocks 2 Toxic Brain Proteins in Alzheimer’s and Parkinson’s
2 articles · Updated · ScienceDaily · Jun 21
Summary
Nature Communications published Baylor College of Medicine findings that tubulin can steer Tau and alpha-synuclein away from toxic clumps and toward normal work inside neurons.
The study argues against simply blocking protein condensates, because those droplets also support healthy brain activity; instead, raising tubulin appears to redirect the proteins within them.
Low tubulin levels—already reported in Alzheimer’s disease—leave fewer microtubules and allow harmful aggregates to form, while added tubulin promotes healthy microtubule assembly in neuron-based assays.
The researchers say that reframes tubulin from a passive victim of neurodegeneration to a potential therapeutic target for selectively limiting protein aggregation in Alzheimer’s and Parkinson’s.
Beyond Alzheimer's, could this tubulin strategy combat other diseases of protein aggregation?
If tubulin is the hero, could boosting it in the brain have a hidden dark side?
2026 Discovery: Tubulin Actively Prevents Toxic Protein Clumps in Alzheimer’s and Parkinson’s Disease
Overview
In March 2026, researchers at Baylor College of Medicine made a breakthrough discovery that changed how we understand neurodegenerative diseases. They found that tubulin, a key structural protein in neurons, plays an active and crucial role in protecting brain cells. Instead of being a passive victim, tubulin prevents the formation of toxic protein clumps made of Tau and alpha-synuclein—proteins linked to Alzheimer’s and Parkinson’s diseases. By engaging these proteins in their normal, healthy functions, tubulin stops them from misfolding and forming harmful aggregates, offering new hope for future treatments.